HYDERABAD: Hyderabad came alive on Sunday as the city shook off the previous day’s bandh and plunged into Diwali celebrations ...

The advisory also urges state regulators to intensify inspections and ensure that no batch of medicine is released without ...

The Union Health Secretary emphasized strict compliance with the Revised Schedule M by all drug manufacturers.

The Delhi government's Drugs Control Department has banned Coldrif Syrup due to adulteration with Diethylene Glycol, which is harmful to health. Stakeholders and the public are advised to refrain from ...

India's drug regulator, CDSCO mandates strict batch testing of all raw materials and finished formulations to prevent toxic ...

The drug regulator emphasised that manufacturers must comply with the Drugs Rules, conduct thorough batch testing of both raw ...

The ‘Coldrif’ cough syrup has come to the spotlight after 16 children died in Madhya Pradesh and at least two in Rajasthan. A ...

Maharashtra FDA halted the sale of Coldrif Syrup (Batch SR-13) due to Diethylene Glycol contamination, linked to deaths of ...

Tata Capital is selling its shares in the price band of Rs 310-326 apiece, which could be applied for a minimum of 46 shares and its multiples to raise Rs 15,511.87 crore between October 06-08.

The Supreme Court on Monday (October 7) issued a slew of significant directions aimed at strengthening road safety measures ...

Several states and UTs, including Punjab, Madhya Pradesh, Puducherry and Kerala, have banned Coldrif cough syrup after tests found dangerous levels of diethylene glycol. The Centre has urged doctors ...